BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10712435)

  • 1. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.
    Kero J; Poutanen M; Zhang FP; Rahman N; McNicol AM; Nilson JH; Keri RA; Huhtaniemi IT
    J Clin Invest; 2000 Mar; 105(5):633-41. PubMed ID: 10712435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
    Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice harboring murine luteinizing hormone receptor promoter/beta-galactosidase fusion genes: different structural and hormonal requirements of expression in the testis, ovary, and adrenal gland.
    Hämäläinen T; Kero J; Poutanen M; Huhtaniemi I
    Endocrinology; 2002 Oct; 143(10):4096-103. PubMed ID: 12239121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
    Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
    Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion.
    Kero JT; Savontaus E; Mikola M; Pesonen U; Koulu M; Keri RA; Nilson JH; Poutanen M; Huhtaniemi IT
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E812-8. PubMed ID: 12773309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
    Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background.
    Nilson JH; Abbud RA; Keri RA; Quirk CC
    Recent Prog Horm Res; 2000; 55():69-89; discussion 89-91. PubMed ID: 11036934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
    Mann RJ; Keri RA; Nilson JH
    Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin.
    Rulli SB; Ahtiainen P; Mäkelä S; Toppari J; Poutanen M; Huhtaniemi I
    Endocrinology; 2003 Nov; 144(11):4980-90. PubMed ID: 12960071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
    Feelders RA; Lamberts SW; Hofland LJ; van Koetsveld PM; Verhoef-Post M; Themmen AP; de Jong FH; Bonjer HJ; Clark AJ; van der Lely AJ; de Herder WW
    J Clin Endocrinol Metab; 2003 Jan; 88(1):230-7. PubMed ID: 12519858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
    Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
    Beuschlein F; Looyenga BD; Bleasdale SE; Mutch C; Bavers DL; Parlow AF; Nilson JH; Hammer GD
    Mol Cell Biol; 2003 Jun; 23(11):3951-64. PubMed ID: 12748296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
    Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
    Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone can participate in down-regulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells.
    El-Hefnawy T; Huhtaniemi I
    Mol Cell Endocrinol; 1998 Feb; 137(2):127-38. PubMed ID: 9605514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells.
    Rao ChV; Zhou XL; Lei ZM
    Biol Reprod; 2004 Aug; 71(2):579-87. PubMed ID: 15084485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid expression in the rat ovary: relationship to cholesterol metabolism.
    Wang L; Menon KM
    Endocrinology; 2005 Jan; 146(1):423-31. PubMed ID: 15459111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features.
    Mazzuco TL; Chabre O; Feige JJ; Thomas M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):196-203. PubMed ID: 16249277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex.
    Meehan TP; Harmon BG; Overcast ME; Yu KK; Camper SA; Puett D; Narayan P
    J Mol Endocrinol; 2005 Apr; 34(2):489-503. PubMed ID: 15821112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.
    Risma KA; Clay CM; Nett TM; Wagner T; Yun J; Nilson JH
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1322-6. PubMed ID: 7877975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.